Introduction: In this study we analysed the angiogenetic effects of 3D scaffolds made from 45S5 bioactive glass (BG) doped with 1 wt. % copper ions in the arteriovenous loop model of the rat. Materials and Methods: An arteriovenous loop was built in the groin of 10 rats and inserted in 1% copper doped 45S5 BG scaffolds and fibrin. The scaffold and the AV loop were inserted in Teflon isolation chambers and explanted 3 weeks after implantation. Afterwards the scaffolds were analyzed by Micro-CT and histology regarding vascularization. Results were compared to plain 45S5 BG-based scaffolds from a previous study. Results: Micro-CT and histological evaluation showed consistent vascularization of the constructs. A tendency towards an increased vascularization in the copper doped BG group compared to plain BG constructs could be observed. However, there was no significant difference in statistical analysis between both groups. Conclusions: This study shows results that support an increased angiogenetic effect of 1% copper doped 45S5 BG compared to regular 45S5 BG scaffolds in the rat arteriovenous loop model although these tendencies are not backed by statistical evidence. Maybe higher copper doses could lead to a statistically significant angiogenetic effect.
Introduction
The successful integration of tissue-engineered samples into a body is dependent on functioning blood supply mechanisms. A reliable blood supply ensures viability of the transplanted cells and tissue and is therefore one of the most important and critical components of tissue engineering strategies [1] . To promote angiogenesis and thus increasing tissue survival in bone tissue engineering, the addition of endothelial cells or angiogenetic growth factors have been used [2, 3] . While some of those strategies have been reported to be successful, there may be even more promising alternatives to deliver pro-angiogenetic factors. A simple way to deliver these factors may be given by using the scaffold material itself. Bioactive glasses are attracting increasing attention as bone regenerative materials [4] . It could be shown that ions washed out of bioactive glasses in contact with bodyfluids have bioactive properties and interact with the surrounding tissue [5] . The use of bioinorganics has multiple advantages compared to the application of growth factors. Growth factors are proteins and can be easily degraded. This sensibility to high temperatures e.g. makes it difficult to integrate them into scaffold structures as production of inorganic scaffolds often requires high temperatures. Additionally, it has been shown that the integration into the scaffold can lead to a more sustained release of bioactive ions [6] . Further-more the use of inorganic elements is more cost effective compared to growth factors. However, the use of the positive effects of ions in vivo is limited by their toxicity in higher concentrations [7, 8] . Copper ions have specific proangiogenetic properties as they stimulate growth of endothelial cells (EC), promote the formation of capillary-like structures and improve scaffold vascularization in vivo [9] [10] [11] . The angiogenetic effect of copper is thought to be achieved through stabilization or up-regulation of the expression of hypoxia inducible factor (HIF) 1α [12] [13] [14] , promoting the expression of VEGF [15, 16] and the expression of the endothelial nitric oxide synthase [17] . Furthermore, copper ions have positive influence on osteoblast cell activity and proliferation [18] . These characteristics make copper an interesting factor in bone tissue engineering. The integration of copper into clinically proven bioactive glasses represents a way of controlled and sustained release to maximize cell survival and success of bony integration given the osteoinductive features of bioactive glasses, in particular 45S5 bioactive glass (45S5 BG) (Composition in wt.%) [19] and the angiogenetic properties of copper ions [20] . Another method of vascularizing samples is through implantation of an arteriovenous loop (AV loop). This concept has been first described by Erol and Spira in 1972 [21] and allows for prefabrication of tissue and makes microsurgical free transplantation of the created tissue possible. For better cell survival the porous chamber is advantageous, whereas the isolation chamber can be used for evaluation of angiogenetic processes in a more controlled environment with less interference from surrounding tissue [22] . Another advantage is, that in the isolation chamber only intrinsic vascularization takes place [23] . In this study copper-doped 45S5 bioactive glass (45S5 Cu1% BG) scaffolds were implanted in the AV-Loop model within an isolation chamber in male Lewis rats and compared to specimens of non-copper-doped 45S5 bioactive glass scaffolds from a previous study [24] . The specimens were examined using micro-CT, histological evaluation and automated evaluation of vascularization.
Materials and methods

Scaffolds
Copper-doped 45S5 BG scaffolds (1 wt.% Cu) were fabricated by the foam replica method as described elsewhere [25] . Complete characterization of these scaffolds in terms of microstructural mechanical properties and degradation behaviour has been also reported before [25] .
Experimental design
As the study included surgical procedures performed on animals, the experiments were approved in advance by the animal care committee of the University of ErlangenNürnberg and the Government of Mittelfranken, Germany (AZ 54-2532.1-24/09). The experiments were conducted on 10 male Lewis rats (Charles River Laboratories, Sulzfeld, Germany) with an initial body weight of 340-390 g. The operations were performed by a veterinary doctor (U. Rottensteiner) under sterile conditions using an operating microscope (Karl Zeiss, Jena, Germany). For comparison, regular plain BG implants from a previous study [24] were used (Group A). Constructs containing copper doped bioactive glass were designated as Group B.
The surgical procedure for the creation of an arteriovenous loop in the left thigh was performed as described previously [26] . All animals received general anaesthesia with Isoflurane (Baxter, Unterschleißheim, Germany). For the creation of an arteriovenous loop (AVL), the left femoral vessels were microsurgically dissected. Using a vein graft from the right femoral vein interposed between the left femoral artery and vein the AV loop was created. Afterwards the AVL was embedded into a custom made teflon chamber (Department of Materials Science, Glass and Ceramics, University of Erlangen) filled with a 45S5 Cu1% BG granula scaffold matrix (nominal granula dimension 2 × 2 × 2 mm 3 ). The matrix contained fibrin gel (Tisseel VH S/D, Baxter Healthcare S.A., Wallisellen, Switzerland) which was made from fibrinogen with a concentration of 10 mg/ml and thrombin with a concentration of 2 I.U./ml. Aprotinin was added to the mixture to delay fibrinolysis, the concentration was 1500 K.I.E./ml. All concentrations refer to the final volume of the fibrin gel. After filling the first half of the chamber with 45S5 Cu1% BG scaffolds and fibrin gel, the AVL was placed on the resulting layer. The rest of the chamber was then filled with the second half of the BG/fibrin gel matrix ( Figure 1 ). Finally, the lid was closed, and the chamber was fixed to the thigh musculature using 4-0 Prolene sutures (Ethicon, Norderstedt, Germany).
Explantation
The explantation was performed 3 weeks after the implantation surgery. After explantation all constructs underwent Micro-CT characterization as well as histological and morphometrical analysis. During the explantation, perfusion of the vessels was performed using Microfil MV-122 (Flowtech, Carver MA, USA). Under general anaesthesia, the abdominal aorta and caval vein were prepared for the perfusion by surgical exposition, incision and cannulation. Afterwards the cannulated aorta was flushed with heparin solution. Flushing was repeated until the fluid exiting the caval vein was macroscopically clear of blood. After removing the blood from the vessels, 20 mL yellow Microfil (MV-122) containing 5% of MV Curing Agent were injected into the aorta. Afterwards, the animals were euthanized by an intracardial injection of a combination of tetracaine, mebenzonium and embutramide (T61, Intervet/MSD Tiergesundheit, Unterschleißheim, Germany). The rat was then cooled down to 4 ∘ C for 24 h, and the chambers were explanted. After removing the specimens from the chamber they were macroscopically inspected and fixed in a 3.5% formaldehyde solution for histological processing. After fixation in formaldehyde the constructs were decalcified using 20% Ethylenediaminetetraacetic Acid solution (EDTA; Sigma-Aldrich Chemie GmbH, Steinheim, Germany). All specimens underwent micro-CT characterization after being decalcified and were histologically analysed. In the process, one animal had to be euthanized and two AV-loops were macroscopically not patent at explantation and therefore not included in the study and further investigated by means of micro-CT and histology.
Micro-CT characterization
For analysis of the vessels contained in the constructs, the samples were examined with a high resolution micro-CT-scanner (Skyscan 1172, Skyscan B.V., now Bruker, Kontich, Belgium) equipped with an 11-MP detector. Scanning was performed with a voltage of 80 kV and a current of 100 mA using no additional source filtering. Overall rotation was 180 ∘ with steps over 0.4 ∘ and a resolution of 6.9
to 8 mm/voxel depending on the size of the sample. Raw data was reconstructed using tomographic reconstruction software (NRecon Client and Server 1.6.4 with GPU support; Skyscan). 3D images were generated from the twodimensional data sets with imaging software (Amira 5.4.1; Visage Imaging, now FEI, Gräfelfing, Germany). In the process, additional skeletonization (Module autoskeleton Amira) was performed to determine the network structure of the vessels. The resulting network classified by breaking it up into segments with individual length and mean diameter. Using a histogram class width of 1 mm, an accumulated vessel length was calculated for each vessel and radius class.
Histological Analysis
All tissue samples were dehydrated after undergoing micro-CT in graded ethanol and embedded in paraffin.
Cross sections with a thickness of 3 µm were obtained from two planes perpendicular to the AVL axis using a Leica microtome (Leica Microsystems, Wetzlar, Germany). The resulting sections were stained with hematoxylin and eosin (H&E) and digital photographs of each H&E-stained cross section were obtained using a Olympus Microscope (Olympus Europa Holding GmbH, Hamburg, Germany) and digital camera (SC30, Olympus). To generate a complete image of one cross section, the photographs taken under four fold magnification were merged using cellSens Dimension V1.5 software (Olympus). Afterwards the cross sections were examined for vascularization.
Automatic quantitative evaluation of vascularization
The automatic evaluation works with the "negative-&posi-tive-experts"-model [27] and the (corrected) nearest-neighbor-classification/k-means-clustering [28] applied on images of histological cross-sections. The program was written in MATLAB using the image processing toolbox and the statistics toolbox. For examination, the images of the complete cross sections (generation as described previously) were used. For discrimination of the vessels, negative experts (sample background, dark objects, like nuclei of H&E-and lectin-staining, etc.) as well as positive experts (vessels) were defined. The images were then transformed from the conventional RGB color space to the CIELAB color space. Using the experts defined before, a model was trained to classify all pixels of the image. After applying the model to the data a binary map was generated containing 'pixels containing vessels' and 'pixels not containing vessels'. 
Statistical analysis
Resulting data were expressed as means ± standard deviation. Results were compared to plain BG constructs from a previous study [24] . Data were analysed using Excel (Microsoft Corp., Redmond, Washington). For statistical analysis, the student t-test was applied. The critical level of statistical significance chosen was p < 0.05.
Results
Micro-computed tomography
All patent specimens were examined regarding vascularization using micro-CT. These images showed a dense vascular network throughout the constructs with the highest vessel density in the area of the entry of the AV-loop into the chamber (Figure 2 ). There were no AVL thromboses detectable in the micro-CT images of all scanned constructs, although there was a large artifact in the distal part of one construct. All specimens showed vessel sprouts emerging from the AVL forming a vascular network. Statistical analysis showed no significant difference between the mean values of all constructs concerning accumulated vessel length of all diameters (p = 0.204) (Figure 3) . Also, the overall length of all vessels did not differ significantly (p = 0.078) although the mean values showed that group B (45S5 Cu1% BG constructs) had about three times as much mean total vessel length than group A (plain 45S5 BG constructs) (878,366.14 ± 965,006.4 µm vs 271,760.33 ± 78213.96 µm) (Figure 4 ).
Histological evaluation
Histological evaluation showed connective tissue filling up the space between the BG scaffold granula in all constructs at the explantation time point ( Figure 5 ). In some animals remnants of the fibrin gel matrix could be observed in the center of the specimens. A perfusion with Microfil was used to make the vessels visible that had sprouted from the AV-Loop. In the histologic slides, their lumina appeared black. The generated tissue contained different cells such as fibroblasts, neutrophils and fat cells. The copper doped 45S5 BG granules were still visible and evenly distributed in all constructs. There were no signs of cell toxicity or inflammation in the vicinity of the matrix granules. 
Automatic quantitative evaluation of vascularization
Automatic assessment of vascularization pattern inside the constructs was feasible. There were no significant differences detectable in all measured parameters. Moreover, the vessel density was 8.98 ± 6. 
Discussion
Angiogenesis is a key factor for the success of scaffold integration and survival in tissue engineering [29, 30] . In this study we evaluated angiogenetic properties of copper doped bioactive glass in the AV-loop model, which itself shows the capability for angiogenesis [31, 32] . Both copper ions and bioactive glasses have been shown to improve angiogenesis in vitro and in vivo [5, 9, 13, 14, 33, 34] . In this study we were not able to show that copper doped 45S5 BG can stimulate significant vessel growth in the AVloop in an isolation chamber. One reason may be that the pro-angiogenetic pathways of copper ions work via stabilization of HIF-1 [12] [13] [14] . The studies showing the influence of copper ions on HIF-1 used cells embedded in fibrin matrices or evaluated cells in vitro. In our study, the only cells present in the isolation chamber were the cells of the AV-loop and those in the circulating blood passing through it. It is possible that more cells with high HIF-1 levels are needed to stimulate a significant increase in vessels sprouting into the isolation chamber [35] . A study from Handel et al. [36] supports this theory, as they were able to show that the angiogenetic potential of 45S5 bioactive glass is increased by adding cells (in this case human adipose tissue-derived stem cells) to the scaffold. Further studies with implanted cells in the isolation chamber to increase the levels of HIF-1 may be sensible. However, the use of mesenchymal stem cells (MSCs) could potentially influence the angiogenetic processes [37] . Another reason for the absence of significant differences in vascularization of the chamber may be that the dosage of copper ions was not correct to trigger the expected results. An overdosage can have toxic effects to endothelial cells, depending on the species that the EC were derived from. It could be shown that the same dose of copper that leads to an increase in proliferation in human umbilical vein endothelial cells (HUVEC) [11, 17] leads to cytotoxic effects in bovine derived corneal endothelial cells [38] . Even if the same material used in this study was shown to improve VEGF expression in human endothelial cells and bone marrow derived stem cells in vitro [15] , the copper content may have no significant angiogenetic or cytotoxic effects on rat endothelial cells. In a study from Frangoulis et al. [39] a 2% copper containing ointment reduced tissue necrosis critical sized flaps and increased VEGF expression. This result may be due to the effect of increased cell survival in an environment with reduced nutrients as observed by Stähli et al. [40] . In the same study, Stähli et al. [40] also reported decreasing levels of HUVEC viability with the same doses of copper applied to HUVECs compared to other studies showing increased viability and proliferation levels [11, 17] . As a possible reason, the inactivation of important nutrients and growth factors by copper ions in the growth medium was discussed [40] . It may be possible that the nutrients or growth factors in vitro react different in comparison to the present in vivo model. To rule out incorrect dosage of copper in BG constructs a study with higher copper concentrations is necessary. According to a study from Stähli et al. a dosage of more than 2.5 wt.% may be the optimal dose for stimulating angiogenesis without the cytotoxic effects [41] . In order to find the optimal dosage, a separate study with different higher doses of copper is recommendable. It is worthwhile noticing that another reason why no statistical difference in vascularization could be measured may be the fact that 45S5 BG itself promotes angiogenesis [5, 24, 33, 34, 42] and that the additional effect of copper does not suffice to produce observable differences in vascularization in the AVloop model investigated here. It should also be considered that the time that the scaffolds were implanted may not have been long enough to build up significant differences in vascularization. Therefore it might be necessary to evaluate the same copper doped 45S5 BG scaffolds in the AVloop model but considering longer implantation time. In previous studies it could be shown that the vascular network is in a remodeling process until 8 weeks after implantation [22, 43] . Therefore, we suggest an implantation time of at least 6 weeks. However the observed results refer only to functional vessels. Vessels in the process of sprouting, that are not perfused cannot be measured with the methods used in this study. To include developing vessels, which might give significant differences, further evaluation of the histological slides using Lectin staining may be sensible [44] . Overall, even if no statistically significant differences between undoped and Cu-doped 45S5 BG scaffolds were identified in this study, the results suggest angiogenetic effects of copper-doped bioactive glass.
Conclusions
In summary, this study has shown results that support an increased angiogenetic effect of copper doped BG scaffolds compared to regular (undoped) 45S5 BG although that no statistical significant differences were detected. Further studies are needed to prove the angiogenetic effect of Cu-BG scaffolds e.g. with increased dosage of copper or longer implantation times.
Confirming that copper doped BG scaffolds significantly increase vascularization of the construct would lead to propose such scaffolds as promising material for bone tissue engineering as they exhibit the excellent characteristics needed for successful creation of bone tissue, subsequent transplantation and integration into bone.
